AIM ImmunoTech (AIM) announced Safety Committee approval to proceed with the Phase 2 portion of the Phase 1b/2 clinical trial involving AIM’s Ampligen and AstraZeneca’s (AZN) anti-PD-L1 immune ...

Bajaj Healthcare receives DCGI approval to manufacture Pimavanserin, a generic medication for treating hallucinations and delusions associated with Parkinson's disease. New Delhi, Jan 30 (PTI) Bajaj ...

Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule. Pimavanserin is an ...

Shares of Bajaj Healthcare surged close to 4% soon after the company said it has received an major approval from the Drug Controller General of India (DCGI) to manufacture both the API as well as ...

James Bickerton is a Newsweek U.S. News reporter based in London, U.K. His focus is covering U.S. politics and world politics. He has covered the intersection between politics and emerging ...

Roughly a week after his inauguration, President Donald Trump’s approval rating is outpacing his disapproval rating. The poll by Echelon Insights showed 51% of respondents approve of the way ...

Today, 538 is unveiling a new polling average for President Donald Trump's job approval rating. Based on the 11 polls released since his inauguration on Jan. 20, Trump's average approval rating ...

An explanation of the methodology for 538's presidential approval average. On Jan. 28, 2025, 538 launched our average of polls of President Donald Trump's approval rating. For Trump's second term ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.